KRTL Holding Group, Inc. manufactures and distributes water. The company is headquartered in Lakewood, Colorado. The company went IPO on 2001-06-21. The firm operates through its subsidiaries, including KRTL Biotech, Inc., KRTL International Corp and Neurogen Brain Balancing, LLC (Neurogen). KRTL Biotech, Inc. is a pharmaceutical company focused on the commercialization of APIs and licensing agreements within the pharmaceutical and nutraceutical sectors. KRTL Biotech, Inc. focuses on biotechnology, particularly in securing and developing global partnerships for the sourcing and distribution of critical APIs and wellness-focused compounds. KRTL International Corp focuses on bridging global markets through international consulting, trade and distribution of advanced bio and agri-technologies and services. Neurogen is a neurotechnology company focused on advanced brain balancing therapies and personalized cognitive optimization systems.
最新の財務諸表(Form-10K)によると、Bank of NT Butterfield & Son Ltdの総資産は$0で、純損失は$0です。
KRTLの主要な財務比率は何ですか?
Bank of NT Butterfield & Son Ltdの流動比率は0、純利益率は0、1株当たり売上高は$0です。
KRTL Holding Group Incの収益はセグメントまたは地域別にどのように分けられていますか?
Bank of NT Butterfield & Son Ltd の最大収益セグメントは Banking Services and Wealth Management で、最新の利益発表における収益は 606,792,000 です。地域別に見ると、Bermuda が Bank of NT Butterfield & Son Ltd の主要市場であり、収益は 273,674,000 です。
KRTL Holding Group Incは収益を上げていますか?
いいえ、最新の財務諸表によると、Bank of NT Butterfield & Son Ltdの純損失は$0です。